InsiderSignalSign in

← Insider buys

David L. Lucchino has sold stock and made no open-market buys since Apr 2020

Director at Korro Bio, Inc., and 1 other company

SEC CIK 0001785288 · Filings on SEC.gov ↗

$0Bought

$11.5MSold

NoneLast buy

Companies

Every filing

27 filings since Apr 2020, newest first

Korro Bio, Inc.

Director

$44K−5.0%Nov 27

Korro Bio, Inc.

Director

$41K−4.0%Nov 22

Frequency Therapeutics, Inc.

President and CEO

$475K−3.0%Mar 2

Frequency Therapeutics, Inc.

President and CEO

$910K−5.0%Feb 10

Frequency Therapeutics, Inc.

President and CEO

$538K−3.0%Feb 5

Frequency Therapeutics, Inc.

President and CEO

$254K−2.0%Feb 4

Frequency Therapeutics, Inc.

President and CEO

$1.4M−10.0%Feb 3

Frequency Therapeutics, Inc.

President and CEO

$391K−3.0%Jan 28

Frequency Therapeutics, Inc.

President and CEO

$1.1M−8.0%Jan 8

Frequency Therapeutics, Inc.

President and CEO

$1.1M−10.0%Jan 6

Frequency Therapeutics, Inc.

President and CEO

Frequency Therapeutics, Inc.

President and CEO

$1.5M−11.0%Dec 16

Frequency Therapeutics, Inc.

President and CEO

$445K−4.0%Dec 10

Frequency Therapeutics, Inc.

President and CEO

$417K−4.0%Dec 9

Frequency Therapeutics, Inc.

President and CEO

$439K−5.0%Dec 3

Frequency Therapeutics, Inc.

President and CEO

$327K−4.0%Nov 3

Frequency Therapeutics, Inc.

President and CEO

$301K−4.0%Oct 5

Frequency Therapeutics, Inc.

President and CEO

$291K−4.0%Sep 3

Frequency Therapeutics, Inc.

President and CEO

$340K−4.0%Aug 5

Frequency Therapeutics, Inc.

President and CEO

$353K−4.0%Jul 2

Frequency Therapeutics, Inc.

President and CEO

$71K−1.0%Jun 4

Frequency Therapeutics, Inc.

President and CEO

$213K−3.0%Jun 2

Frequency Therapeutics, Inc.

President and CEO

$190K−2.0%May 12

Frequency Therapeutics, Inc.

President and CEO

$85K−1.0%May 7

Frequency Therapeutics, Inc.

President and CEO

$80K−1.0%May 4

Frequency Therapeutics, Inc.

President and CEO

$50K−1.0%Apr 21

Frequency Therapeutics, Inc.

President and CEO

$79K−1.0%Apr 17

Filings come from SEC EDGAR. Not investment advice.